Although nonkeratinizing NPC is characterized by a rich lymphocytic infiltration and high programmed death ligand 1 (PD-L1) expression in tumor tissue, the expression levels of PD-1/PD-L1 was limited to predict the efficacy of immunotherapy (13–17). The gene discussed is CD274; the disease is nasopharyngeal carcinoma.